Aetna Company Profile (NYSE:AET)

About Aetna (NYSE:AET)

Aetna logoAetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers' compensation administrative services and health information technology (HIT) products and services. The Health Care segment consists of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an Insured basis and an employer-funded basis, and emerging businesses products and services. The Group Insurance segment includes group life insurance and group disability products. Its products are offered on an Insured basis.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Managed Health Care
  • Sub-Industry: Managed Health Care
  • Symbol: NYSE:AET
  • CUSIP: 00817Y10
  • Web:
  • Market Cap: $52.35 billion
  • Outstanding Shares: 332,100,000
Average Prices:
  • 50 Day Moving Avg: $158.11
  • 200 Day Moving Avg: $149.63
  • 52 Week Range: $104.59 - $164.52
  • Trailing P/E Ratio: 35.02
  • Foreward P/E Ratio: 15.49
  • P/E Growth: 1.74
Sales & Book Value:
  • Annual Revenue: $62.2 billion
  • Price / Sales: 0.84
  • Book Value: $46.38 per share
  • Price / Book: 3.40
  • Annual Dividend: $2.00
  • Dividend Yield: 1.3%
  • EBITDA: $6.06 billion
  • Net Margins: 2.52%
  • Return on Equity: 20.52%
  • Return on Assets: 5.35%
  • Debt-to-Equity Ratio: 0.46%
  • Current Ratio: 0.48%
  • Quick Ratio: 0.48%
  • Average Volume: 1.80 million shs.
  • Beta: 0.53
  • Short Ratio: 3.37

Frequently Asked Questions for Aetna (NYSE:AET)

What is Aetna's stock symbol?

Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."

How often does Aetna pay dividends? What is the dividend yield for Aetna?

Aetna announced a quarterly dividend on Friday, September 29th. Investors of record on Thursday, October 12th will be given a dividend of $0.50 per share on Friday, October 27th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.27%. The ex-dividend date of this dividend is Wednesday, October 11th. View Aetna's Dividend History.

How will Aetna's stock buyback program work?

Aetna declared that its Board of Directors has approved a stock buyback program on Friday, April 7th 2017, which permits the company to buyback $4,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase up to 98% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's leadership believes its stock is undervalued.

How were Aetna's earnings last quarter?

Aetna Inc. (NYSE:AET) issued its earnings results on Thursday, August, 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $2.34 by $1.08. The firm earned $15.52 billion during the quarter, compared to the consensus estimate of $15.34 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. Aetna's revenue was down 2.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.21 EPS. View Aetna's Earnings History.

When will Aetna make its next earnings announcement?

Aetna is scheduled to release their next quarterly earnings announcement on Tuesday, October, 31st 2017. View Earnings Estimates for Aetna.

What guidance has Aetna issued on next quarter's earnings?

Aetna issued an update on its FY17 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of $9.45-9.55 for the period, compared to the Thomson Reuters consensus estimate of $8.99.

Where is Aetna's stock going? Where will Aetna's stock price be in 2017?

19 analysts have issued twelve-month target prices for Aetna's stock. Their predictions range from $132.00 to $185.00. On average, they expect Aetna's share price to reach $163.69 in the next twelve months. View Analyst Ratings for Aetna.

What are analysts saying about Aetna stock?

Here are some recent quotes from research analysts about Aetna stock:

  • 1. According to Zacks Investment Research, "Aetna’s shares outperformed the industry year to date. We expect the company to derive long-term growth from its Government business. Cost-reduction initiatives and growing ACO collaborations pave the way for long-term growth. A strong balance sheet is another positive. Its International expansion is also perceived as an opportunity in the face of increased regulation in the U.S. Following strong second-quarter results, Aetna rasied its earnings guidance which cements investors' confidence in the company. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 6.3% upward over the last 90 days. Aetna has, however, been incurring losses in its public exchange business and has been exiting exchanges to avoid losses from this business. Furthermore, its membership growth remains under pressure. Increasing medical benefit ratios are also likely to hurt margins." (10/16/2017)
  • 2. Cantor Fitzgerald analysts commented, "There is life after Humana. CEO Mark Bertolini opened the meeting discussing life after Humana. With a continued focus to grow its government business, Mr. Bertolini indicated that Humana represented a means to an end." Instead, AET will now chose to build its government business organically. We believe the company will also pursue acquisitions to build out its capabilities in specific geographies. CFO Shawn Guertin identified Medicare as a great growth opportunity, but characterized Medicaid as a good opportunity. Growth in Medicaid slowed recently due to two contract losses and potential for structural changes to Medicaid exist." (5/12/2017)
  • 3. Royal Bank Of Canada analysts commented, "After the close on Monday, April 24, Humana pre-released 1Q17 EPS ahead of its investor meeting, which will be held on Tuesday, April 25. 1Q17 Adjusted EPS for the quarter was $2.75 vs. our estimate of $2.50 and FactSet consensus of $2.49." (4/24/2017)
  • 4. Oppenheimer Holdings, Inc. analysts commented, "Overall, we believe Humana is well positioned for growth, given the political support in Washington, ample strategic capital to deploy and the potential for upside to its current earnings base."Ultimately, this will also remain a desirable asset that could be acquired by another insurer." (3/31/2017)
  • 5. Jefferies Group LLC analysts commented, "AET's 4Q EPS was strong (beat by 13%), while initial 2017 guidance was below consensus on both the top and bottom line. As always, favorable prior period development (PPD) is excluded from the outlook and could generate upside. Looking to 2018, earnings growth should accelerate from buyback tailwinds and exiting HIX. We bump up our EPS projections for capital deployment, but remain Hold as the stock seems fairly valued." (2/1/2017)

Who are some of Aetna's key competitors?

Who are Aetna's key executives?

Aetna's management team includes the folowing people:

  • Mark T. Bertolini, Chairman of the Board, Chief Executive Officer
  • Karen S. Lynch, President
  • Shawn M. Guertin, Chief Financial Officer, Executive Vice President, Chief Enterprise Risk Officer
  • Thomas J. Sabatino Jr., Executive Vice President, General Counsel
  • Gary W. Loveman Ph.D., Executive Vice President - Consumer and Health Services
  • Margaret M. McCarthy, Executive Vice President - Operations and Technology
  • Harold L. Paz M.D., Executive Vice President, Chief Medical Officer
  • Francis S. Soistman Jr., Executive Vice President - Government Services
  • Sharon Virag, Chief Accounting Officer, Vice President, Controller
  • Edward J. Ludwig, Lead Independent Director

Who owns Aetna stock?

Aetna's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Fulton Bank N.A. (0.01%), Curbstone Financial Management Corp (0.00%) and Eqis Capital Management Inc. (0.00%). Company insiders that own Aetna stock include Francis S Soistman Jr, Gary W Loveman, Jeffrey E Garten, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini, Molly Joel Coye and Shawn M Guertin. View Institutional Ownership Trends for Aetna.

Who sold Aetna stock? Who is selling Aetna stock?

Aetna's stock was sold by a variety of institutional investors in the last quarter, including Eqis Capital Management Inc. and Fulton Bank N.A.. Company insiders that have sold Aetna stock in the last year include Francis S Soistman Jr, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini and Shawn M Guertin. View Insider Buying and Selling for Aetna.

Who bought Aetna stock? Who is buying Aetna stock?

Aetna's stock was acquired by a variety of institutional investors in the last quarter, including Curbstone Financial Management Corp. View Insider Buying and Selling for Aetna.

How do I buy Aetna stock?

Shares of Aetna can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aetna's stock price today?

One share of Aetna stock can currently be purchased for approximately $157.64.

MarketBeat Community Rating for Aetna (NYSE AET)
Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  660 (Vote Outperform)
Underperform Votes:  414 (Vote Underperform)
Total Votes:  1,074
MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Aetna (NYSE:AET) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 6 Hold Ratings, 13 Buy Ratings
Consensus Rating:Buy (Score: 2.68)
Consensus Price Target: $163.69 (3.84% upside)
Consensus Price Target History for Aetna (NYSE:AET)
Price Target History for Aetna (NYSE:AET)
Analysts' Ratings History for Aetna (NYSE:AET)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/16/2017BMO Capital MarketsInitiated CoverageMarket Perform$175.00N/AView Rating Details
10/13/2017Jefferies Group LLCBoost Price TargetHold$163.00 -> $165.00N/AView Rating Details
9/12/2017ArgusReiterated RatingBuy$165.00 -> $185.00LowView Rating Details
8/17/2017Morgan StanleyBoost Price TargetOverweight$172.00 -> $179.00LowView Rating Details
8/9/2017Cantor FitzgeraldReiterated RatingOverweight$150.00 -> $175.00LowView Rating Details
8/7/2017Deutsche Bank AGBoost Price TargetHold$157.00 -> $163.00LowView Rating Details
8/4/2017Royal Bank Of CanadaBoost Price TargetOutperform -> Outperform$162.00 -> $171.00MediumView Rating Details
7/13/2017Credit Suisse GroupReiterated RatingOutperform$160.00 -> $165.00LowView Rating Details
6/28/2017Citigroup Inc.Initiated CoverageBuy -> Buy$180.00LowView Rating Details
5/27/2017Cowen and CompanySet Price TargetBuy$145.00 -> $170.00N/AView Rating Details
5/17/2017Bank of America CorporationReiterated RatingBuy$160.00 -> $168.00MediumView Rating Details
5/16/2017Stifel NicolausBoost Price TargetBuy -> Buy$150.00 -> $158.00LowView Rating Details
5/15/2017Barclays PLCReiterated RatingOverweight$162.00LowView Rating Details
5/11/2017Cleveland ResearchUpgradeNeutral -> BuyLowView Rating Details
4/3/2017CIBCReiterated RatingOutperformLowView Rating Details
3/31/2017Oppenheimer Holdings, Inc.Reiterated RatingOutperformLowView Rating Details
1/31/2017Sanford C. BernsteinDowngradeOutperform -> Market PerformN/AView Rating Details
1/24/2017Leerink SwannDowngradeOutperform -> Market Perform$135.00N/AView Rating Details
1/4/2017Piper Jaffray CompaniesInitiated CoverageNeutral$136.00N/AView Rating Details
9/22/2016Evercore ISIInitiated CoverageBuy$128.00N/AView Rating Details
8/17/2016FBR & CoReiterated RatingHoldN/AView Rating Details
7/21/2016Wolfe ResearchDowngradeOutperform -> Peer PerformN/AView Rating Details
6/2/2016Wells Fargo & CompanyReiterated RatingBuyN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
2/2/2016WedbushLower Price TargetNeutral$130.00 -> $120.00N/AView Rating Details
10/30/2015J P Morgan Chase & CoLower Price Target$144.00 -> $141.00N/AView Rating Details
(Data available from 10/19/2015 forward)


Earnings History for Aetna (NYSE:AET)
Earnings by Quarter for Aetna (NYSE:AET)
Earnings History by Quarter for Aetna (NYSE AET)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2017$2.07N/AView Earnings Details
8/3/2017Q2 2017$2.34$3.42$15.34 billion$15.52 billionViewListenView Earnings Details
5/2/2017Q1 2017$2.36$2.71$15.39 billion$15.17 billionViewListenView Earnings Details
1/31/2017Q416$1.44$1.63$15.84 billion$15.73 billionViewListenView Earnings Details
10/27/2016Q316$2.02$2.07$15.71 billion$15.78 billionViewListenView Earnings Details
8/2/2016Q216$2.12$2.21$15.69 billion$15.95 billionViewListenView Earnings Details
4/28/2016Q116$2.23$2.30$15.46 billion$15.69 billionViewListenView Earnings Details
2/1/2016Q415$1.21$1.37$14.93 billion$15.09 billionViewListenView Earnings Details
10/29/2015Q315$1.77$1.90$15.22 billion$15.00 billionViewListenView Earnings Details
8/4/2015Q215$1.82$2.05$15.43 billion$15.13 billionViewListenView Earnings Details
4/28/2015Q115$1.96$2.39$15.48 billion$15.09 billionViewListenView Earnings Details
2/3/2015Q414$1.22$1.22$14.59 million$14.77 millionViewListenView Earnings Details
10/28/2014Q214$1.58$1.79$14.63 billion$14.70 billionViewListenView Earnings Details
7/29/2014Q114$1.61$1.69$13.98 billion$14.50 billionViewListenView Earnings Details
4/24/2014Q413$1.56$1.98$13.69 billion$13.97 billionViewListenView Earnings Details
2/6/2014Q313$1.36$1.34$13.14 billion$13.13 billionViewListenView Earnings Details
10/29/2013Q213$1.53$1.53$12.89 billion$12.99 billionViewListenView Earnings Details
7/30/2013Q2 2013$1.39$1.52$12.02 billion$11.56 billionViewListenView Earnings Details
4/30/2013Q1 2013$1.38$1.50$9.65 billion$9.51 billionViewListenView Earnings Details
1/31/2013Q4 2012$0.96$0.94$8.97 billion$8.96 billionViewListenView Earnings Details
10/25/2012Q312$1.34$1.55$8.96 billion$8.90 billionViewN/AView Earnings Details
7/31/2012$1.25$1.31ViewN/AView Earnings Details
4/26/2012$1.39$1.34ViewN/AView Earnings Details
2/1/2012$0.96$0.97ViewN/AView Earnings Details
10/27/2011$1.14$1.40ViewN/AView Earnings Details
7/27/2011$1.07$1.35ViewN/AView Earnings Details
4/28/2011$0.97$1.43ViewN/AView Earnings Details
2/4/2011$0.62$0.63ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Aetna (NYSE:AET)
2017 EPS Consensus Estimate: $8.34
2018 EPS Consensus Estimate: $10.02
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.29$2.40$2.33
Q2 20174$2.30$2.38$2.35
Q3 20174$2.08$2.42$2.17
Q4 20174$1.26$1.74$1.49
Q1 20181$2.76$2.76$2.76
Q2 20181$2.72$2.72$2.72
Q3 20181$2.70$2.70$2.70
Q4 20181$1.84$1.84$1.84
(Data provided by Zacks Investment Research)


Current Dividend Information for Aetna (NYSE:AET)
Next Dividend:10/27/2017
Annual Dividend:$2.00
Dividend Yield:1.27%
Dividend Growth:7.70% (3 Year Average)
Payout Ratio:43.67% (Trailing 12 Months of Earnings)
20.92% (Based on This Year's Estimates)
19.65% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Aetna (NYSE:AET)

Dividend History by Quarter for Aetna (NYSE AET)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Aetna (NYSE:AET)
Insider Ownership Percentage: 0.90%
Institutional Ownership Percentage: 89.52%
Insider Trades by Quarter for Aetna (NYSE:AET)
Institutional Ownership by Quarter for Aetna (NYSE:AET)
Insider Trades by Quarter for Aetna (NYSE:AET)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/18/2017Karen S LynchPresidentSell15,271$161.91$2,472,527.61View SEC Filing  
9/15/2017Margaret M MccarthyEVPSell10,288$162.85$1,675,400.80View SEC Filing  
6/7/2017Margaret M MccarthyEVPSell27,028$149.23$4,033,388.44View SEC Filing  
5/17/2017Mark T BertoliniChairmanSell103,547$140.79$14,578,382.13View SEC Filing  
3/23/2017Shawn M GuertinInsiderSell29,602$129.35$3,829,018.70View SEC Filing  
3/8/2017Francis S Soistman JrVPSell6,607$131.98$871,991.86View SEC Filing  
9/7/2016Jeffrey E. GartenDirectorSell7,100$116.51$827,221.00View SEC Filing  
8/23/2016Shawn M GuertinInsiderSell45,328$120.21$5,448,878.88View SEC Filing  
5/10/2016Margaret M MccarthyEVPSell39,169$114.45$4,482,892.05View SEC Filing  
5/3/2016Mark T BertoliniCEOSell33,510$114.00$3,820,140.00View SEC Filing  
3/15/2016Gary W LovemanEVPBuy8,970$111.45$999,706.50View SEC Filing  
2/22/2016Molly Joel CoyeDirectorSell1,175$106.28$124,879.00View SEC Filing  
12/23/2015Margaret M MccarthyEVPSell18,373$109.97$2,020,478.81View SEC Filing  
12/22/2015Mark T. BertoliniCEOSell26,996$110.00$2,969,560.00View SEC Filing  
8/14/2015Joseph M ZubretskyEVPSell179,087$118.66$21,250,463.42View SEC Filing  
8/13/2015Franklin Barbara HackmanDirectorSell2,064$118.47$244,522.08View SEC Filing  
3/31/2015Joseph M ZubretskyEVPSell200,000$107.96$21,592,000.00View SEC Filing  
3/27/2015Joseph M ZubretskyEVPSell86,958$107.24$9,325,375.92View SEC Filing  
3/26/2015Joseph M ZubretskyInsiderSell162,066$106.98$17,337,820.68View SEC Filing  
3/26/2015Margaret M MccarthyEVPSell27,670$106.04$2,934,126.80View SEC Filing  
3/25/2015Franklin Barbara HackmanDirectorSell3,000$108.75$326,250.00View SEC Filing  
3/17/2015William James CasazzaVPSell14,000$105.07$1,470,980.00View SEC Filing  
3/2/2015Molly Joel CoyeDirectorSell2,500$100.27$250,675.00View SEC Filing  
2/10/2015Rajan ParmeswarVPSell5,300$95.60$506,680.00View SEC Filing  
6/16/2014Molly Joel CoyeDirectorSell1,650$80.60$132,990.00View SEC Filing  
6/12/2014William James CasazzaVPSell15,906$80.58$1,281,705.48View SEC Filing  
5/27/2014Franklin Barbara HackmanDirectorSell2,665$77.26$205,897.90View SEC Filing  
2/19/2014Rajan ParmeswarVPSell3,600$69.46$250,056.00View SEC Filing  
12/30/2013Mark BertoliniCEOSell130,272$68.08$8,868,917.76View SEC Filing  
12/27/2013William James CasazzaVPSell10,299$68.25$702,906.75View SEC Filing  
8/26/2013William James CasazzaVPSell15,745$64.66$1,018,071.70View SEC Filing  
6/18/2013William James CasazzaVPSell40,598$62.00$2,517,076.00View SEC Filing  
5/21/2013Molly Joel CoyeDirectorSell2,000$60.38$120,760.00View SEC Filing  
5/20/2013Joseph P NewhouseDirectorSell14,000$59.15$828,100.00View SEC Filing  
5/15/2013Rajan ParmeswarVPSell1,435$60.13$86,286.55View SEC Filing  
2/6/2013Karen RohanVPBuy4,035$49.53$199,853.55View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Aetna (NYSE:AET)
Latest Headlines for Aetna (NYSE:AET)
DateHeadline logoU.S. judge will likely rule next week on healthcare payments - October 18 at 9:44 PM logoAmazon, Anthem, Congress Put Drug Benefits Firms in Hot Spot - October 18 at 4:40 PM logoAmazon, Anthem, Congress Put Drug Benefits Firms in Hot Spot - October 18 at 4:40 PM logoRide On UnitedHealth Q3 Strength with These ETFs - October 18 at 4:40 PM logoWhite House says Trump opposes Senate's bipartisan Obamacare deal - October 18 at 4:40 PM logoAre insurers 'enriched' by Obama health law, as Trump says? - October 18 at 4:30 PM logoEarnings Visibility Keeps Aetna (AET) a Buy - October 18 at 12:16 PM logoInsurers Boosted by Bipartisan Health Plan; Siris Lands Synchronoss Unit - ICYMI - October 17 at 9:30 PM logoHealth care trades that still work: 6 picks - October 17 at 9:30 PM logoAetna to Announce Third-Quarter 2017 Results - October 17 at 9:30 PM logoA Look at Aetna’s Dividend Yield Path - October 17 at 4:26 PM logoAetna (AET) versus Molina Healthcare (MOH) Head to Head Review - October 17 at 8:26 AM logoAetna Inc. (AET) Now Covered by BMO Capital Markets - October 16 at 7:28 PM logoT-Mobile, Sprint aim to announce merger without asset divestitures - October 16 at 4:29 PM logoAetna (AET) versus The Competition Head to Head Review - October 16 at 2:10 AM logoExclusive: T-Mobile, Sprint Aim to Announce Merger Without Asset Divestitures-Sources - New York Times - October 16 at 1:38 AM logoTrump to scrap a crucial part of Obamacare - October 15 at 3:26 PM logoWall Street Reaches Intraday Records Even as Healthcare Slumps - October 15 at 1:32 AM logoAetna Inc. (AET) Rating Increased to Buy at Zacks Investment Research - October 14 at 9:00 PM logoSorry Everbody, But Trump Hasn't Instigated The Obamacare Apocalypse - October 14 at 8:29 PM logo[$$] It’s Open-Enrollment Time: What Health Plan Should I Pick? - October 13 at 8:30 PM logoJefferies Group LLC Boosts Aetna Inc (AET) Price Target to $165.00 - October 13 at 7:34 PM logoTrump to sign executive order today changing aspects of Obamacare - Seeking Alpha - October 13 at 3:30 PM logoAetna Once Again Outperforms Industry Average in Latest Medicare Star Ratings - October 13 at 3:30 PM logoThe Zacks Analyst Blog Highlights: Royal Dutch Shell, Morgan Stanley, Aetna, Johnson Controls International and LyondellBasell Industries - October 13 at 3:29 PM logoHow The CEOs of America’s Top Companies Are Stepping Up In Big Ways - October 13 at 3:29 PM logoTop Analyst Reports for Royal Dutch Shell, Morgan Stanley & Aetna - October 13 at 2:20 AM logoPotential Takeover Candidate Molina Names New CEO - October 11 at 9:39 PM
News IconUPDATE 1-Molina Healthcare appoints Joseph Zubretsky chief executive - October 11 at 4:36 PM logoAetna, Inc. breached its 50 day moving average in a Bearish Manner : AET-US : October 11, 2017 - October 11 at 4:36 PM logoAetna Inc. (AET) Ex-Dividend Date Scheduled for October 11, 2017 - Nasdaq - October 10 at 4:44 PM logoDividend Coverage: This Health Care Benefit Company has an Annualized Payout of $2.00; Will Trade Ex-Dividend on October 11, 2017 - October 10 at 4:44 PM logoBreakfast Technical Briefing on Health Care Plans Stocks -- Express Scripts, Aetna, Cigna, and Anthem - PR Newswire (press release) - October 9 at 4:40 PM logoCash Dividend On The Way From Aetna (AET) - Nasdaq - October 9 at 4:40 PM logo[$$] Boutique Office Buildings Attract Big-Name Tenants - October 9 at 1:26 AM logoSchumer rejects Trump bid to negotiate on ACA replacement - Seeking Alpha - October 8 at 3:24 PM logoAnalyzing Aetna (AET) & Catamaran Corp (SXCI) - October 8 at 12:28 PM logoAetna Inc. (AET) Receives Consensus Recommendation of "Buy" from Analysts - October 8 at 12:44 AM logoWhy Aetna Inc (AET) Delivered An Inferior ROE Compared To The Industry - October 7 at 4:25 PM logoWhy Companies Can’t Just Write Checks to Do Good - October 6 at 3:53 PM logoAetna (AET) Shares Raised to Strong Buy from a Buy - - October 5 at 12:50 PM logoAnalyzing Aetna (AET) & Its Rivals - October 5 at 12:16 AM logoAetna (AET) Shares Raised to Strong Buy from a Buy - October 4 at 3:17 PM logoA.M. Best Assigns Credit Ratings to Texas Health + Aetna Health Insurance Company and Texas Health + Aetna Health Plan, Inc. - October 4 at 2:56 PM logoAetna Board of Directors Declares Quarterly Cash Dividend - October 2 at 3:23 PM logo Analysts Expect Aetna Inc. (AET) Will Post Quarterly Sales of $15.09 Billion - October 1 at 7:56 AM logoAetna Inc. (AET) Announces Quarterly Dividend of $0.50 - September 29 at 3:48 PM logoBerger & Montague: Aetna to Provide Emergency Relief to Members Affected by HIV/AIDS Privacy Breach - September 29 at 3:11 PM logoDoes Aetna Inc’s (AET) PE Ratio Signal A Selling Opportunity? - September 29 at 3:11 PM logoRepublicans revise repeal of Obamacare to 2019 - Seeking Alpha - September 28 at 9:13 PM



Aetna (AET) Chart for Thursday, October, 19, 2017

This page was last updated on 10/19/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.